Clinical Trials Directory

Trials / Completed

CompletedNCT04880083

Feeding Tolerance and Gut Maturation of Infants Consuming a Formula Rich in Glycoprotein

Feeding Tolerance and Gut Maturation of Infants Consuming a Formula Rich in Glycoprotein: A Single-arm, Open-label, Prospective Interventional Study Including a Breastfed Reference Group

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Société des Produits Nestlé (SPN) · Industry
Sex
All
Age
3 Days – 28 Days
Healthy volunteers
Accepted

Summary

This is a non-randomized, single-arm, open-label, prospective interventional study using a commercially available starter infant formula in healthy term formula-fed infants with a parallel group of healthy term breast-fed infants as reference group. Approximately 120 male and female infants (60 per group) who are 3-28 days old and are exclusively or predominately formula-feeding or breastfeeding will be enrolled.

Detailed description

Breastmilk contains an abundance of structurally diverse compounds having important physiologic roles. These include glycoproteins which are biologically active and involved in infant gut, immune and brain development (Jiang and Lönnerdal 2016). The overall purpose of this study is to study the effectiveness of a term infant formula rich in glycoprotein (formula-fed group) on gastrointestinal tolerance, and gastrointestinal health in healthy term infants compared to a breast-fed reference group. We hypothesize that there will be comparable gastrointestinal tolerance in formula-fed and breast-fed and that fecal bifidobacteria changes in early infancy in the formula-fed group are similar to that of breast-fed infants.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCommercially Available Starter Infant FormulaStudy formula is provided in powder form and will be administered orally, ad libitum, via an infant feeding bottle and the volume of formula offered to the infant will be guided by the recommended feeding table for the age group or by physician recommendation. The amount consumed by the infant will vary by each infant's weight and appetite.

Timeline

Start date
2021-07-09
Primary completion
2022-12-28
Completion
2022-12-28
First posted
2021-05-10
Last updated
2025-07-02

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04880083. Inclusion in this directory is not an endorsement.